Jinyu Bio-Technology Co Ltd (600201) — Strategic Asset Allocation Index
Jinyu Bio-Technology Co Ltd (600201) has a Strategic Asset Allocation Index of 32.8% as of June 2023. Strategic assets (PP&E of CN¥1.78 Billion plus long-term investments of CN¥-) total CN¥1.78 Billion, measured against net assets of CN¥5.43 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 600201 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Jinyu Bio-Technology Co Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Jinyu Bio-Technology Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 32.8%, representing strategic assets of CN¥1.78 Billion against net assets of CN¥5.43 Billion CNY. See 600201 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Jinyu Bio-Technology Co Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jinyu Bio-Technology Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Jinyu Bio-Technology Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.6% | CN¥1.80 Billion | CN¥1.80 Billion | CN¥- | CN¥5.35 Billion | ▲ +0.9 pp |
| 2021 | 32.7% | CN¥1.82 Billion | CN¥1.82 Billion | CN¥- | CN¥5.56 Billion | ▲ +0.0 pp |
| 2020 | 32.7% | CN¥1.72 Billion | CN¥1.72 Billion | CN¥- | CN¥5.26 Billion | ▼ -1.2 pp |
| 2019 | 33.9% | CN¥1.65 Billion | CN¥1.65 Billion | CN¥- | CN¥4.87 Billion | ▲ +0.5 pp |
| 2018 | 33.4% | CN¥1.74 Billion | CN¥1.50 Billion | CN¥248.32 Million | CN¥5.22 Billion | ▲ +12.5 pp |
| 2017 | 20.9% | CN¥937.65 Million | CN¥702.39 Million | CN¥235.26 Million | CN¥4.48 Billion | ▲ +0.4 pp |
| 2016 | 20.5% | CN¥769.57 Million | CN¥606.05 Million | CN¥163.52 Million | CN¥3.75 Billion | ▼ -19.6 pp |
| 2015 | 40.1% | CN¥829.21 Million | CN¥718.33 Million | CN¥110.88 Million | CN¥2.07 Billion | ▲ +4.7 pp |
| 2014 | 35.4% | CN¥577.74 Million | CN¥577.74 Million | CN¥- | CN¥1.63 Billion | ▼ -0.8 pp |
| 2013 | 36.2% | CN¥464.04 Million | CN¥464.04 Million | CN¥- | CN¥1.28 Billion | ▼ -0.3 pp |
| 2012 | 36.5% | CN¥392.92 Million | CN¥392.92 Million | CN¥- | CN¥1.08 Billion | ▲ +5.3 pp |
| 2011 | 31.1% | CN¥308.50 Million | CN¥308.50 Million | CN¥- | CN¥991.13 Million | ▼ -6.0 pp |
| 2010 | 37.1% | CN¥313.35 Million | CN¥313.35 Million | CN¥- | CN¥844.15 Million | ▼ -2.6 pp |
| 2009 | 39.7% | CN¥297.98 Million | CN¥297.98 Million | CN¥- | CN¥750.98 Million | ▼ -0.4 pp |
| 2008 | 40.1% | CN¥290.28 Million | CN¥290.28 Million | CN¥- | CN¥723.47 Million | ▼ -7.7 pp |
| 2007 | 47.8% | CN¥338.96 Million | CN¥338.96 Million | CN¥- | CN¥708.54 Million | ▲ +1.0 pp |
| 2006 | 46.8% | CN¥283.69 Million | CN¥283.69 Million | CN¥- | CN¥605.80 Million | ▼ -3.6 pp |
| 2005 | 50.4% | CN¥290.95 Million | CN¥290.95 Million | CN¥- | CN¥577.16 Million | ▲ +9.6 pp |
| 2004 | 40.8% | CN¥248.62 Million | CN¥248.62 Million | CN¥- | CN¥609.02 Million | ▲ +2.4 pp |
| 2003 | 38.4% | CN¥220.49 Million | CN¥220.49 Million | CN¥- | CN¥573.94 Million | ▲ +3.6 pp |
| 2002 | 34.8% | CN¥184.27 Million | CN¥184.27 Million | CN¥- | CN¥529.82 Million | ▲ +9.9 pp |
| 2001 | 24.9% | CN¥128.79 Million | CN¥128.79 Million | CN¥- | CN¥517.19 Million | ▼ -15.6 pp |
| 2000 | 40.5% | CN¥139.54 Million | CN¥139.54 Million | CN¥- | CN¥344.80 Million | — |